Urine Rapid Tests
When minutes count, LabCorp's Rapid Test programs offer drugs of abuse screening that is rapid, reliable, and right. Urine Rapid Test, Point-of-Collection Testing (POCT), provides on-site screening for drugs of abuse and urine specimen validity following chain-of-custody protocol.
LabCorp performs urine rapid tests in many of its patient service centers (PSCs) nationwide, or customers may choose to perform tests in their own facilities. LabCorp’s certified laboratories offer GC/MS confirmation for non-negative Rapid Test drug screens.
LabCorp Solutions Rapid Test process involves the collector running an initial screen on-site at the point of collection. Collections performed in a LabCorp PSC include the collector entering the screening results via a Web-based tool. Once results are entered, they are downloaded into the laboratory system, enabling customers to obtain electronic reports and statistical summary data. The Rapid Test result entry Web tool is available for use by customers who choose to perform the screening in their own facilities.
Program Features:
- Negative results generally available within four hours
- Rapid tests performed at LabCorp-owned and managed sites
- Walk-in rapid test collections performed at most sites
- Multiple urine drug screening panels available, including screening for oxycodone and ecstasy
- GC/MS confirmation of non-negative specimens available in LabCorp certified laboratories
- Multiple state-of-the-art reporting methods available
Testing Options Include:
Available urine drug screen rapid tests range from one to nine drugs including:
Specimen Validity Screening
- amphetamine
- methamphetamine
- marijuana metabolite
- cocaine
- opiates
- phencyclidine (PCP)
- barbiturates
- benzodiazepines
- methadone
- propoxyphene
- oxycodone
LabCorp offers rapid tests that provide information on the possible adulteration of urine samples submitted for drugs of abuse testing.